Professor Perrior has led drug discovery teams that have delivered numerous development candidates across several therapeutic areas. Following his education at the University of Cambridge Trevor undertook academic research at Cambridge, Oxford and in the USA. He then held a number of senior R&D roles in the pharmaceutical and biotechnology companies ICI, Zeneca, AstraZeneca and Celltech, where he worked on sites in the UK, USA, and Switzerland.
In 2005 he joined NCE Discovery as Chief Scientific Officer, and when NCE Discovery merged with Domainex he became Director of Research for the enlarged company. Trevor is also a scientific consultant to a number of venture capital and charitable funds, and is the Visiting Professor of Medicinal Chemistry at University of Sussex where he chairs the Translational Drug Discovery Steering Committee.